Bio-Rad Laboratories, Inc. BIO reported better-than-expected second-quarter financial results on Thursday.Bio-Rad Laboratories reported quarterly earnings of $2.61 per share which beat the analyst consensus estimate of$1.76 per share. The company reported quarterly sales of $651.600 million which beat the analyst consensus estimate of$615.110 million.Bio-Rad Laboratories narrowed its FY2025 sales guidance from $2.541 billion-$2.606 billion to $2.567 billion-$2.593 billion.Norman Schwartz, Bio-Rad’s Chairm ...